Loading clinical trials...
Loading clinical trials...
Impact of no Carrageenan Diet on Glucose Tolerance in Prediabetes
Participants will be randomly assigned to either regular or no-carrageenan prepared diets to determine whether the no-carrageenan leads to improvement in glucose tolerance. Hemoglobin A1c is the primary outcome measure.
Subjects will be randomly assigned to a diet. They will at onset have hemoglobin A1c values between 5.7% and 6.4%. Baseline glucose tolerance test will be performed, as well as measures of inflammation and fecal microbiome. Interim tests will be performed at six weeks. Subjects will participate for 12 weeks, at which time they will be re-evaluated.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
University of Illinois at Chicago
Chicago, Illinois, United States
Start Date
February 1, 2016
Primary Completion Date
December 1, 2018
Completion Date
December 1, 2018
Last Updated
September 30, 2019
48
ESTIMATED participants
No-carrageenan diet
OTHER
Regular Diet
OTHER
Lead Sponsor
University of Illinois at Chicago
NCT05119179
NCT06252038
NCT04943861
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions